A Potential Boron Neutron Capture Therapy Agent Selectively Suppresses High-Grade Glioma: In Vitro and in Vivo Exploration.
Alamón C, Dávila B, García MF, Nievas S, Dagrosa MA, Thorp S, Kovacs M, Trias E, Faccio R, Gabay M, Zeineh N, Weizman A, Teixidor F, Viñas C, Gavish M, Cerecetto H, Couto M.
Alamón C, et al. Among authors: couto m.
Mol Pharm. 2023 May 1;20(5):2702-2713. doi: 10.1021/acs.molpharmaceut.3c00152. Epub 2023 Apr 4.
Mol Pharm. 2023.
PMID: 37013916